美国心脏协会COVID-19心血管病登记:住院COVID-19患者卒中分析
校正后卒中风险不因种族而异,且急性缺血性卒中/TIA与院内死亡无独立关联。
要点
- 住院COVID-19患者急性缺血性卒中/TIA占0.75%,其他类型卒中占0.61%。
- 校正合并症和病情严重度后,缺血性卒中风险在中青年人群中最高,而非高龄。
- 急性缺血性卒中/TIA在校正模型中与院内死亡无独立关联。
核心结论
- 缺血性卒中风险不因种族而异,校正合并症与疾病严重程度后中青年风险最高,提示存在独立于年龄相关动脉粥样硬化通路的机制。
主要发现
- 160例(0.75%)发生急性缺血性卒中/TIA,129例(0.61%)发生其他类型卒中。
- 非缺血性卒中中,脑出血44例(15.2%)、蛛网膜下腔出血33例(11.4%)、硬膜外/硬膜下出血21例(7.3%)、脑静脉窦血栓2例(0.7%)、未分类卒中24例(8.3%)。
- 从COVID-19症状出现至缺血性卒中的中位时间为11.5天(四分位距17.8),中位NIHSS评分为11(四分位距17)。
- 合并急性缺血性卒中/TIA者高血压、糖尿病和心房颤动患病率高于无卒中者;ICU入住和机械通气与急性缺血性卒中/TIA风险升高相关,高龄非预测因素。
- 校正模型中急性缺血性卒中/TIA与院内死亡无关联。
临床怎么用
- 住院COVID-19患者需警惕缺血性卒中/TIA,尤其合并高血压、糖尿病、心房颤动或需ICU/机械通气者。
- 中青年COVID-19患者出现神经系统症状时不应因年龄较轻而降低对缺血性卒中的警惕。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) may be associated with increased risk for ischemic stroke. We present prevalence and characteristics of strokes in patients with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 infection enrolled in the American Heart Association COVID-19 Cardiovascular Disease Registry. METHODS: In this quality improvement registry study, we examined demographic, baseline clinical characteristics, and in-hospital outcomes among hospitalized COVID-19 patients. The primary outcomes were ischemic stroke or transient ischemic attack (TIA) and in-hospital death. RESULTS: Among 21 073 patients with COVID-19 admitted at 107 hospitals between January 29, 2020, and November 23, 2020, 160 (0.75%) experienced acute ischemic stroke/TIA (55.3% of all acute strokes) and 129 (0.61%) had other types of stroke. Among nonischemic strokes, there were 44 (15.2%) intracerebral hemorrhages, 33 (11.4%) subarachnoid hemorrhages, 21 (7.3%) epidural/subdural hemorrhages, 2 (0.7%) cerebral venous sinus thromboses, and 24 (8.3%) strokes not otherwise classified. Asians and non-Hispanic Blacks were overrepresented among ischemic stroke/TIA patients compared with their overall representation in the registry, but adjusted odds of stroke did not vary by race. Median time from COVID-19 symptom onset to ischemic stroke was 11.5 days (interquartile range, 17.8); median National Institutes of Health Stroke Scale score was 11 (interquartile range, 17). COVID-19 patients with acute ischemic stroke/TIA had higher prevalence of hypertension, diabetes, and atrial fibrillation compared with those without stroke. Intensive care unit admission and mechanical ventilation were associated with higher odds of acute ischemic stroke/TIA, but older age was not a predictor. In adjusted models, acute ischemic stroke/TIA was not associated with in-hospital mortality. CONCLUSIONS: Ischemic stroke risk did not vary by race. In contrast to the association between older age and death from COVID-19, ischemic stroke risk was the highest among middle-aged adults after adjusting for comorbidities and illness severity, suggesting a potential mechanism for ischemic stroke in COVID-19 independent of age-related atherosclerotic pathways.
引用
- Shakil SS, Emmons-Bell S, Rutan C, et al. Stroke Among Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Stroke. 2021. PMID: 34702063. doi:10.1161/STROKEAHA.121.035270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。